Closure of Buy Back

October 30, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Rotunda Exchange Plaza, Plot No. C/1, G Block Building, P.J. Towers, Bandra-Kurla Complex, Dalal Street, Fort, Mumbai — 400 001 Bandra (East), Mumbai- 400 051 Scrip Code: 540025 Symbol: ADVENZYMES Ref: ISIN: INE837H01020 Dear Sir/ Madam, Sub: Intimation regarding the closure of Buyback of fully paid-up equity shares of ₹ 2/- each (Rupees Two only) (“Equity Share(s)”) of Advanced Enzyme Technologies Limited (“Company”) from the Open Market through stock exchange mechanism pursuant to the provisions of the SEBI (Buy-Back of Securities) Regulations, 2018 as amended (“Buyback Regulations”) and the Companies Act, 2013 and Rules made thereunder, as amended (“Act”). Re: Intimation under Regulation 30 read with Part A of Schedule III, and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended. This is further to (i) our letter dated August 08, 2026 informing the outcome of the meeting of our Board of Directors ("Board") approving the Buyback and (ii) our letter dated August 11, 2026 regarding publication of the Public Announcement dated August 10, 2026 for the Buyback. Pursuant to the resolution passed by the Board on August 08, 2026, the Company approved the Buyback of Company’s fully paid-up Equity Shares, at a buyback price not exceeding ₹ 500/- (Rupees Five Hundred only) per Equity Share (“Maximum Buyback Price”) from the shareholders/ beneficial owners of the Company (other than those who are Promoters, members of the Promoter Group and persons in control of the Company) (“Eligible Shareholders”) excluding Transaction Costs payable in cash for an aggregate amount not exceeding ₹ 697,000,000 (Rupees Six Hundred and Ninety Seven Million only) (hereinafter referred to as the “Maximum Buyback Size”), being 9.99% and 5.09% of the aggregate of the total paid-up Equity Share capital and free reserves of the Company based on the latest standalone and consolidated audited financial statements of the Company respectively, as at March 31, 2026 and which is not more than 10% of the total paid-up Equity Share capital and free reserves of the Company, whichever sets out a lower amount, in accordance with the proviso to Regulation 5(i)(b) of the Buyback Regulations and in accordance with the provisions contained in the Buyback Regulations and the Act (hereinafter referred to as the “Buyback”). The Company commenced the Buyback on Friday, August 14, 2026, from the Eligible Shareholders from the Open Market through the Stock Exchanges mechanism under the Buyback Regulations. In this regard, please be informed that as on October 30, 2026, the Company has bought back 2,410,906 (Two Million Four Hundred Ten Thousand Nine Hundred and Six)) Equity Shares at an average price of ₹ 289.09/- (Rupees Two Hundred and Eighty Nine and Nine Paisa only) per Equity Share and utilized ₹ 696,962,962.22 (Rupees Six Hundred Ninety-Six Million Nine Hundred Sixty-Two Thousand Nine Hundred Sixty-Two and Twenty-Two Paise), which is 99.99% of the Maximum Buyback Size (excluding Transaction Costs). Accordingly, the Buyback Committee in its meeting held today approved the closure of the Buyback, pursuant to the terms of the Public Announcement, with effect from the end of market hours today i.e., Friday, October 30, 2026, prior to the expiry of the Sixty-Six Working Days from the commencement date of the Buyback. The Company has already extinguished 1,713,324 (One Million Seven Hundred Thirteen Thousand Three Hundred and Twenty-Four) Equity Shares bought back till September 2026 and will extinguish remaining 697,582 (Six Hundred Ninety-Seven Thousand Five Hundred and Eighty-Two) Equity Shares bought back during October 2026 within the timelines prescribed under the Buyback Regulations. The details of the Pre Buyback and Post Buyback shareholding pattern of the Company is enclosed herewith as Annexure-I. The post Buyback public announcement (“Post Buyback Public Announcement”) will be released in due course in accordance with the provisions of the Buyback Regulations. The aforesaid intimation is also being uploaded on the website of the Company i.e. www.advancedenzymes.com. Thanking You Yours faithfully For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head-Legal Annexure-I The shareholding pattern of the Company Pre Buyback and Post Buyback, is as under: Sr. Category of Pre Buyback Post Buyback* No. Shareholders (as on August 08, 2026) (as on October 30, 2026) Number of % to the Number of % to the Equity existing Equity existing Share Equity Share Equity held Share Held Share capital capital A Promoter and 48,419,485 43.24 48,419,485 44.19 Promoter Group B Public Shareholders 63,556,665 56.76 61,145,759 55.81 C1 Shares underlying - - - - C2 Shares held by - - - - Employee Trust C Non Promoter- Non - - - - Public (C1+C2) Total (A+B+C) 111,976,150 100 109,565,244 100 *The Company has already extinguished 1,713,324 (One Million Seven Hundred Thirteen Thousand Three Hundred and Twenty-Four) Equity Shares bought back till September 2026 and is in the process of extinguishing 697,582 (Six Hundred Ninety Seven Thousand Five Hundred and Eighty Two) Equity Shares that have been bought back during October 2026. The share capital post completion of the Buyback (“Post Buyback”) is provided assuming extinguishment of all Equity Shares bought back by the Company.